RIGL Operating Cash Flow Growth
Rigel Pharmaceuticals Inc · Operating Cash Flow Growth
RIGL Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported20.60%period ending
RIGL TTM Cash from Operations YoY % (-116.06% → 20.60%)
Year-over-year change
High-resolution chart · PNG
RIGL operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 20.6043% | |
| 122.7333% | |
| 140.3959% | |
| 535.5145% | |
| 634.736% | |
| 632.6399% | |
| 647.9889% | |
| 150.1027% | |
| 63.0929% | |
| 87.198% | |
| 92.2137% | |
| 69.8146% | |
| 50.9002% | |
| -26,730.102% | |
| -1,354.8146% | |
| -855.2704% | |
| -32,916.9082% | |
| 100.2839% | |
| 111.2638% | |
| 120.3018% | |
| 100.4997% | |
| -56.8038% | |
| -25.7167% | |
| -128.8272% | |
| -61.435% | |
| -22.3133% | |
| 29.436% | |
| 77.5827% | |
| 70.7478% | |
| 55.1048% | |
| 24.1513% | |
| -28.275% | |
| -16.5358% | |
| -8.0263% | |
| -2.1979% | |
| 8.956% | |
| -17.4066% | |
| -16.3131% | |
| -224.1319% | |
| -213.0706% | |
| -91.1389% | |
| -80.5988% | |
| 66.4344% | |
| 66.4814% | |
| 55.869% | |
| 54.3307% | |
| 18.9493% | |
| 17.0632% | |
| 13.2518% | |
| 11.0904% | |
| -1.02% | |
| -7.8221% | |
| -16.1026% | |
| -21.0684% | |
| -22.7993% | |
| -103.4262% | |
| -61.6954% | |
| -246.4888% | |
| -248.4179% | |
| -406.4389% | |
| -783.9807% | |
| 150.6895% | |
| 145.4791% | |
| 112.3785% | |
| 106.4498% | |
| 8.2379% | |
| 0.7139% | |
| -25.8304% | |
| -43.337% | |
| -65.231% | |
| -98.2838% | |
| -54.8877% | |
| -49.6745% | |
| -55.247% | |
| -45.6831% | |
| -85.8409% | |
| -40.702% | |
| -4.8622% | |
| -1.8937% | |
| 18.0996% | |
| -4.2913% | |
| -16.5003% | |
| 7.8161% | |
| 15.8549% | |
| 17.9855% | |
| 13.1424% | |
| -17.6079% | |
| -14.9047% | |
| -28.7942% | |
| -14.5525% | |
| 6.0473% | |
| -62.2861% | |
| -49.303% | |
| -111.211% | |
| -116.0566% |